Dallas, TX (PRWEB) March 09, 2015
Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. Complete report with TOC is available at http://www.lifescienceindustryresearch.com/point-of-care-diagnostic-testing-world-markets.html .
This report describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor’s offices. The study defines the dollar volume of point of care sales and makes five year projections–both in the U.S. and worldwide–including Europe, Asia and Latin America. It also examines in detail the point of care sector for 25 individual country markets. A detailed summary of all important instruments in each clinical market is provided with emphasis on newly introduced products. Moreover, parallel areas where rapid detection is important using hand-held devices such as rapid detection of food pathogens and infectious diseases (MRSA, herpes simplex, avian flu, West Nile virus and typhoid) are discussed. Growth moderators and developing trends in point of care applications, as well as technology platform innovations and connectivity questions are examined in detail.
The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the U.S. and worldwide. Each company is discussed in depth, with a section on its history, product lines, business and marketing analysis, and a subjective commentary of the company’s market position. Detailed tables and charts with sales forecasts and market data are also included. Order a Purchase copy of this report at http://www.lifescienceindustryresearch.com/purchase?rname=380. (This is a premium report priced at US$3850 for a single user License.)
Corporate Profiles discussed in this report include Abaxis, Inc., Abbott Laboratories, AccuBioTech Co., Ltd., Accriva Diagnostics, AccuTech, LLC, ACON Laboratories, Inc., Acrongenomics, AgaMatrix, Aerscher Diagnostics, LLC, Akers Biosciences, Inc., Alere, Alfa Scientific Designs, Inc., American Bio Medica Corporation, Any Biotech Oyo Ltd., Ark Therapeutics Group Plc, Arkray, Inc., Atlas Genetics Ltd., Atonomics A/S, Audit Diagnostics, Augurix Diagnostics Ltd., Axis-Shield Plc (Alere), Axxin, Bayer Corp., Beckman Coulter (Danaher Corporation), BioLytical Laboratories, Biomerica, Inc., bioMérieux, BiOracle, Bio-Rad Laboratories, Inc., BioScan Screening Systems, Inc., BioSite, Calmark Sweden AB, Calypte Biomedical Corporation, Chembio Diagnostic, Inc., Chempaq A/S, Cholestech, Claros Diagnostics (OPKO Healthcare), CompuCyte Corporation (Thorlabs), Concateno Plc, Dexcom, Diagnostics for All, Enigma Diagnostics Ltd., EY Laboratoires, Inc., Eurotrol, Exalenz Bioscience, GenBio, Genzyme Diagnostics (Acquired by Sekisui Chemical , Co., Ltd.), Guided Therapeutics, Inc. (SpectRx, Inc.), Helena Laboratories, Hema Diagnostic Systems, LLCm, HemoCue AB, HemoSense, Home Diagnostics (Nipro Diagnostics) IND Diagnostic, Instrumentation Laboratory (IL)/Werfen Group, Jant Pharmacal Corporation, Johnson & Johnson, Lein Applied Diagnostics, LifeAssays AB, LifeSign, LLC, Medica Corporation, Mediwatch, Medix Biochemica, MedMira Laboratories, MELA Sciences (Formerly Electro-Optical Sciences), A. Menarini Diagnostics, Meretek Diagnostics Group, Meridian Bioscience, Micronics, Minimed, Inc., Mitsubishi Chemical Holdings USA, Inc., Mitsubishi Kagaku Iatron, Nanogen (ELITech Group), New Horizons Diagnostics, Nova Biomedical, OraSure Technologies, Inc., Orion Diagnostica, Polymedco, Inc., Polymer Technology Systems, Inc., Prima Biomedical Company, QBC Diagnostics, Qualigen, Quest Diagnostics, Inc., Quidel Corporation, Radiometer Medical, Response Biomedical Corp., Roche Diagnostics, Savyon Diagnostics, Seegene, Sekisui Diagnostics, LLC, Shanghai Ruicare Medical Co., Ltd., Shenzhen Fitconn Technology Co., Ltd., Shionogi & Co., Ltd., Siemens AG, Siloam Biosciences, Inc., Spectral Diagnostics, Inc., StatSure Diagnostic Systems, Inc., Step Detect Associates, LLC, Strategic Diagnostics, Inc., Techne Corporation, Telcare, Trinity Biotech Plc, Väsamed, Inc.
“New Entrants to the Point of Care Market includes”: Alliance International Co., Ltd., Alverix, Inc., Analyticon Biotechnologies AG, Ativa Medical Corporation, Aquila Diagnostic Systems, Inc., ArcDia International Oyo Ltd., Artron Laboratories, Inc., Atlas Link Biotech Co., Ltd., Audit Diagnostics, Autobio Diagnostics Co., Ltd., Biocartis SA, BioFire Diagnostics, Inc., BioHelix Corporation, BioMedomics, Biosensia Ltd., Curetis AG, DxNA, LLC, Echo Therapeutics, Inc., Gentag, Inc., Great Basin Corporation, Immunexpress Group, Innovative Biosensors, Inc., Integrated Diagnostics, Integrity Applications, MBio Diagnostics, Inc., Menssana Research, Inc., Metaara Medical Technologies, Inc., QuantuMDx Group, Venaxis, Inc., Vivacta Limited, Wave 80 Biosciences, Veredus Laboratories Pte Ltd., Via Medical Corporation, Vital Diagnostics, Inc.
Explore more reports on Diagnostics at http://www.lifescienceindustryresearch.com/category/diagnostics .
Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.